INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.400
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
INmune Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -41.27 | -30.01 | -27.3 | -30.34 | -12.1 | -7.68 | |
| Other Amortization | 0.12 | 0.22 | 0.24 | 0.13 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 0.09 | - | - | - | |
| Stock-Based Compensation | 7.73 | 7.37 | 7.15 | 4.8 | 3.11 | 4.1 | |
| Other Operating Activities | - | - | - | - | - | -1.54 | |
| Change in Accounts Payable | 6.89 | 2.72 | 1.4 | 2.26 | 1.08 | -0.13 | |
| Change in Other Net Operating Assets | 0.79 | 7.72 | -4.27 | -5.35 | -1.03 | -0.13 | |
| Operating Cash Flow | -25.75 | -11.98 | -22.69 | -28.5 | -8.94 | -5.38 | |
| Other Investing Activities | - | - | - | -15 | - | - | |
| Investing Cash Flow | - | - | - | -15 | - | - | |
| Long-Term Debt Issued | - | - | - | 14.95 | - | - | |
| Total Debt Issued | - | - | - | 14.95 | - | - | |
| Long-Term Debt Repaid | - | -5 | - | - | - | - | |
| Net Debt Issued (Repaid) | -10 | -5 | - | 14.95 | - | - | |
| Issuance of Common Stock | 27.79 | 0.78 | 0.73 | 81.41 | 24.91 | 12.21 | |
| Repurchase of Common Stock | - | - | - | - | -1.01 | - | |
| Financing Cash Flow | 17.79 | -4.23 | 0.73 | 96.36 | 23.9 | 12.21 | |
| Foreign Exchange Rate Adjustments | -0.3 | -0.1 | -0.7 | -0.01 | 0.02 | -0.02 | |
| Net Cash Flow | -8.26 | -16.31 | -22.66 | 52.84 | 14.97 | 6.81 | |
| Free Cash Flow | -25.75 | -11.98 | -22.69 | -28.5 | -8.94 | -5.38 | |
| Free Cash Flow Margin | -61307.14% | -7729.03% | -6065.78% | -15748.07% | -81300.00% | - | |
| Free Cash Flow Per Share | -1.36 | -0.67 | -1.27 | -1.77 | -0.75 | -0.52 | |
| Cash Interest Paid | 1.05 | 1.78 | 1.37 | 0.56 | - | - | |
| Levered Free Cash Flow | -10.76 | -1.4 | -13.27 | -16.53 | -4.73 | -3.49 | |
| Unlevered Free Cash Flow | -9.8 | -0.2 | -12.25 | -16.66 | -4.73 | -3.49 | |
| Change in Net Working Capital | -8.44 | -11.02 | 3.18 | 3.23 | 0.2 | 0.24 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.